Weekly Biotech Buzz: BMRN Cuts Jobs, FDA Approves New Mpox Vaccine, MRK Halts 2 Keytruda Studies

As biotech companies reprioritize their research and development activities, the sector continues to face layoffs. Unfortunately, this week was no exception. The FDA greenlighted a new vaccine for Mpox, which is the second for this viral infection, amid increasing cases in Africa.

from RTT - Top Story https://ift.tt/Ybg7k52
via IFTTT